Ignite Creation Date:
2024-05-06 @ 3:39 AM
Last Modification Date:
2024-10-26 @ 11:37 AM
Study NCT ID:
NCT02342847
Status:
COMPLETED
Last Update Posted:
2019-01-25
First Post:
2014-12-30
Brief Title:
Observational Study of Quality of Live in Patients With Metastatic Pancreatic Cancer
Sponsor:
Celgene
Organization:
Celgene
Study Overview
Official Title:
Observational Cohort Study of Health-related Quality of Life in Patients Initiating Treatment With Chemotherapy for Metastatic Pancreatic Cancer
Status:
COMPLETED
Status Verified Date:
2019-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
aLIVE
Brief Summary:
This is an observational post-authorization prospective follow-up multi-centre national study designed to describe the spectrum of health-related quality of life in patients with metastatic pancreatic cancer previously untreated with chemotherapy This study is designed to observe patients treated in routine clinical practice without the exclusion limitations of a clinical trial Patients will be enrolled in 7 Spanish sites In all cases the decision to treat patients will be performed prior to the decision to include the patient in the study
Given the observational nature of the study follow-up of patients will be performed according to standard clinical practice of each site
Given the observational nature of the study follow-up of patients will be performed according to standard clinical practice of each site
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None